文献速递创伤与烧伤复苏、休克与脓毒症

基于格式塔评估或ABC评分入组的前瞻性随机试验患者结局

Outcomes of patients enrolled in a prospective and randomized trial on basis of gestalt assessment or ABC score.
PubMed 文献 · J Trauma Acute Care Surg · 2024-02-12
一句话结论PROPPR试验中,ABC评分<2时依据医师格式塔评估入组的创伤患者占36%,其结局与ABC评分≥2入组者相同。

本研究为PROPPR试验的二次分析,比较ABC评分≥2与ABC评分<2时依据医师格式塔评估(PG)入组的创伤患者特征与结局。680例中438例(64%)按ABC≥2入组,242例(36%)按PG入组;PG组年龄更大、白人比例更高、钝性伤更多、低血压和心动过速更轻。两组损伤严重度评分相近(26 vs 27),各时间点死亡率、止血时间及大量输血比例均无显著差异。结论提示PG可在ABC<2时识别需大量输血的创伤患者。

要点

  • 680例中438例(64%)按ABC评分≥2入组,242例(36%)在ABC<2时按医师格式塔评估(PG)入组。
  • PG组较ABC组年龄更大(中位44岁,IQR 28-59,p<0.001)、白人更多(70.3% vs 60.3%,p=0.014)、钝性伤更多(77.3% vs 37.2%,p<0.001)。
  • PG组低血压和心动过速均轻于ABC组(均p<0.001),但两组损伤严重度评分相近(26 vs 27)。
  • 两组各时间点死亡率均无显著差异;止血时间(PG组108分钟 vs ABC组100分钟)及大量输血比例(44.2% vs 47.3%)相近(p=0.071)。
  • ABC<2时按PG入组者占36%,其结局与ABC≥2入组者相同。

适用人群与场景

  • PROPPR试验入组的创伤患者,按ABC评分≥2或ABC<2时由主治创伤外科医师依据格式塔评估(PG)入组。
  • PG组患者较ABC组年龄更大(中位44岁,IQR 28-59)、白人比例更高(70.3% vs 60.3%)、钝性伤更多(77.3% vs 37.2%),低血压和心动过速更轻(均p<0.001)。

诊断标准与关键阈值

  • ABC评分≥2分作为入组标准;ABC评分<2分时由主治创伤外科医师依据格式塔评估(PG)决定入组。

研究设计与关键结果

  • 研究类型为PROPPR前瞻性随机试验的二次分析,共680例,438例(64%)按ABC评分≥2入组,242例(36%)在ABC<2时按PG入组。
  • PG组与ABC组损伤严重度评分分别为26和27;在1:1:1治疗臂中占比分别为50.8%和49.1%。
  • 两组各时间点(1、3、6、12、18、24小时及30天)死亡率均无显著差异。
  • 止血时间PG组108分钟 vs ABC组100分钟;需大量输血(>10单位/24小时)比例44.2% vs 47.3%;达到关键给药阈值(>3单位/1小时)比例84.7% vs 89.5%;上述比较p=0.071。
  • PG组较ABC组年龄更大(中位44岁,IQR 28-59,p<0.001)、白人比例更高(70.3% vs 60.3%,p=0.014)、钝性伤比例更高(77.3% vs 37.2%,p<0.001),低血压和心动过速更轻(均p<0.001)。

证据类型、等级与局限

  • 证据类型:前瞻性随机试验(PROPPR)的二次分析;证据等级:预后与流行病学,Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,早期识别可能需要大量输血的创伤患者对临床救治、资源使用和临床试验患者选择均很重要。
  • 在PROPPR试验中,ABC评分<2时依据医师格式塔评估入组的患者占36%,其结局与ABC评分≥2入组者相同。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial rapidly enrolled patients based on an Assessment of Blood Consumption (ABC) ≥ 2 score, or physician gestalt (PG) when ABC score was <2. The objective of this study was to describe what patients were enrolled by the two methods and whether patient outcomes differed based on these enrollments. We hypothesized that there would be no differences in outcomes based on whether patients were enrolled via ABC score or PG.

METHODS: Patients were enrolled with an ABC ≥ 2 or by PG when ABC was <2 by the attending trauma surgeon. We compared 1-hour, 3-hour, 6-hour, 12-hour, 18-hour, and 24-hour mortality, 30-day mortality, time to hemostasis, emergent surgical or interventional radiology procedure and the proportion of patients who required either >10 units of blood in 24 hours or >3 units in 1 hour.

RESULTS: Of 680 patients, 438 (64%) were enrolled on the basis of an ABC score ≥2 and 242 (36% by PG when the ABC score was <2). Patients enrolled by PG were older (median, 44; interquartile range [IQR], 28-59; p < 0.001), more likely to be White (70.3% vs. 60.3%, p = 0.014), and more likely to have been injured by blunt mechanisms (77.3% vs. 37.2%, p < 0.001). They were also less hypotensive and less tachycardic than patients enrolled by ABC score (both p < 0.001). The groups had similar Injury Severity Scores in the ABC ≥ 2 and PG groups (26 and 27, respectively) and were equally represented (49.1% and 50.8%, respectively) in the 1:1:1 treatment arm. There were no significant differences between the ABC score and PG groups for mortality at any point. Time to hemostasis (108 for patients enrolled on basis of Gestalt, vs. 100 minutes for patients enrolled on basis of ABC score), and the proportion of patients requiring a massive transfusion (>10 units/24 hours) (44.2% vs. 47.3%), or meeting the critical administration threshold (>3 unit/1 hour) (84.7% vs. 89.5%) were similar ( p = 0.071).

CONCLUSION: Early identification of trauma patients likely to require a massive transfusion is important for clinical care, resource use, and selection of patients for clinical trials. Patients enrolled in the PROPPR trial based on PG when the ABC score was <2 represented 36% of the patients and had identical outcomes to those enrolled on the basis of an ABC score of ≥2.

LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Baird EW, Lammers DT, Abraham PJ, et al. Outcomes of patients enrolled in a prospective and randomized trial on basis of gestalt assessment or ABC score. J Trauma Acute Care Surg. 2024. PMID: 38342992. doi:10.1097/TA.0000000000004276

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。